Summary
The clearest overlap between MGF and SS-31 is that both converge around Signaling modulator. Their typical research and application settings separate fairly clearly: MGF is more often discussed in the realm of Musculoskeletal health, whereas SS-31 is more often associated with the realm of Aging and longevity and Cardiovascular health. Both appear to work through Signaling modulator, but the functional emphasis still separates, with MGF leaning toward Anabolic growth and Tissue repair and healing and SS-31 leaning toward Mitochondrial function modulation, Antioxidant activity, and Neuroprotection and cognition. MGF has a more natural endogenous origin, while SS-31 is closer to synthetic design background with MGF in Preclinical development and SS-31 in Clinical phase 2. SS-31 incorporates d-amino acid substitution and amidation features that are not part of MGF, while their sequence patterns also diverge, with MGF showing protein-mimetic sequence features and SS-31 showing cationic amphipathic features.